In the other single-cell RNA-seq analysis using the Brain Immune Atlas, we found that FCGR2B was almost expressed in tumor-associated macrophages (TAMs) and dendritic cells (DCs) and was expressed at higher levels in recurrent GBM samples than in newly diagnosed samples (Figures 5C, D). This evidence concerns the gene FCGR2B and neoplasm.